Case Study: Accelerating Recruitment for an Early-Phase Oncology Study

Key Highlights

Phase I
Clinical Pharmacology Study
36
Patients Enrolled
2
Months Recruitment Period
1
Site, Bulgarian Research Centre

Delivering a Complex Phase I Clinical Pharmacology Study in Bulgaria

Clarenta supported an early-phase oncology study evaluating the pharmacokinetics and safety of an intravenous fixed-dose antiemetic combination in adult cancer patients receiving a single cycle of highly emetogenic chemotherapy.

Conducted at one external clinical research centre in Bulgaria, the Phase I study required intensive pharmacokinetic sampling, precise operational coordination and accelerated patient recruitment.

The Challenge:

The external clinical research centre had limited experience conducting Phase I studies and required additional early-phase expertise and resources to manage the study’s intensive clinical pharmacology procedures.

The study presented several operational challenges:

  • Time-sensitive pharmacokinetic sampling required precise coordination
  • Recruitment had to be completed within a compressed timeframe
  • Study procedures needed to align with patients’ chemotherapy schedules
  • The short participation period required rapid data collection, review and follow-up
  • Samples had to be handled and processed according to defined timelines

Our Solution:

We implemented an integrated early-phase recruitment and site-support model.

  • Provided experienced research nurses to support intensive pharmacokinetic sampling
  • Assigned a dedicated site manager to coordinate the site team and study activities
  • Provided on-site study-coordinator support
  • Supported patient identification, screening and recruitment
  • Coordinated sample handling and study logistics
  • Supported timely eCRF data entry and query resolution
  • Maintained the Investigator Site File
  • Supported monitoring visits
  • Maintained close communication among the investigator, site personnel and wider study team

The Outcome:

We supported the enrollment of 36 patients at one Bulgarian clinical research centre within approximately two months.

Our integrated operational model enabled the centre to manage intensive Phase I pharmacokinetic sampling and complete recruitment within the targeted period.

Planning an operationally demanding early-phase study?
Discover how Clarenta can support patient recruitment, clinical monitoring and time-sensitive clinical pharmacology procedures across early-phase research sites.